Biocon Biologics receives 5 procedural observations after US FDA inspection at Bengaluru facility
The US FDA completed a pre-license inspection of Biocon Biologics’ biosimilars manufacturing site at Biocon Park between April 20 and April 29, 2026
The US FDA completed a pre-license inspection of Biocon Biologics’ biosimilars manufacturing site at Biocon Park between April 20 and April 29, 2026
Visit underscores push for self-reliance in essential medical consumables and India’s ambition to become a global medtech manufacturing hub
The pharmaceutical segment led growth, generating Rs. 337 crore in revenue, while the crop protection business contributed Rs. 157 crore
Honeywell Quality Management Review helps manufacturers boost efficiency and quality compliance
Revolutionary technology will further boost OneSource’s scientific services offerings
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
A committee of two Joint Drugs Controllers has been constituted at CDSCO to monitor the process of inspection, reporting, and subsequent action to ensure compliance to the Drugs & Cosmetics Act, 1940
Subscribe To Our Newsletter & Stay Updated